Reply to: “Crowell et al. Idiopathic Central Nervous System Inflammatory Disease in the Setting of HLA-B27 Uveitis”

"Reply to: “Crowell et al. Idiopathic Central Nervous System Inflammatory Disease in the Setting of HLA-B27 Uveitis”." Ocular Immunology and Inflammation, 27(6), pp. 918–919

This article refers to:

Idiopathic Central Nervous System Inflammatory Disease in the Setting of HLA-B27 Uveitis

This article is referred to by:

Reply to Tobin and Keegan’s “Reply to Idiopathic Central Nervous System Inflammatory Disease in the Setting of HLA-B27 Uveitis”

DECLARATION OF INTEREST

The authors report no conflicts of interest. The authors alone are responsible for the content and writing of the paper.

Additional information

Funding

Dr. Tobin receives research funding from the Kern Center for the Science of Healthcare Delivery, MedImmune, Inc., Alexion Pharmaceuticals, Inc. and Biogen, IDEC. Dr. Keegan has research funded by Biogen, and receives publishing royalties for Common Pitfalls in Multiple Sclerosis and CNS Demyelinating Diseases.